AxoSim empowers advancements in human neuroscience, neuroprotection and neuroregeneration. Its NerveSim® and BrainSim® platforms are revolutionizing how biopharmaceutical companies develop neurological drugs. AxoSim delivers human data, faster. This reduces clinical failure and enables companies to develop effective drugs more quickly and at lower costs. AxoSim works with its clients to save research and development time and money, which fosters innovation and accelerates breakthroughs in treating the world’s most devastating neurological diseases such as Alzheimer's, ALS, Parkinson's and Multiple Sclerosis.